The role of the cytomegalovirus antigenemia assay in the detection and prevention of cytomegalovirus syndrome and disease in solid organ transplant recipients: A review of the British Columbia experience

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 16, Issue 6, 2005, Pages 335-341

  Greanya, Erica D ^a   Partovi, Nilufar ^a,g   Yoshida, Eric M ^a,b   Shapiro, R Jean ^a,c   Levy, Robert D ^a,d   Sherlock, Chris H ^a,e   Stephens, Gwen M ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Liver Transplant Program   (Canada)

^c Renal Transplant Program   (Canada)

^d Lung Transplant Program   (Canada)

^e British Columbia Transplant Society   (Canada)

^f BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^g VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Antigenemia; Cytomegalovirus; Solid organ transplantation

Indexed keywords

GANCICLOVIR;

CANADA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EARLY DIAGNOSIS; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PHYSICAL EXAMINATION; PREDICTION; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 30644471593     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/679386     Document Type: Review

References (24)

1. Patel R, Snydman DR, Rubin RH, et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996;61:1279-89.
2. Nichols WG, Boeckh M. Recent advances in the therapy and prevention of CMV infections. J Clin Virol 2000;16:25-40.
3. Goossens VJ, Blok MJ, Christiaans MH, Sillekens P, Middeldorp JM, Bruggeman CA. Early detection of cytomegalovirus in renal transplant recipients: Comparison of PCR, NASBA, pp65 antigenemia, and viral culture. Transplant Proc 2000;32:155-8.
4. Brennan DC. Cytomegalovirus in renal transplantation. J Am Soc Nephrol 2001;12:848-55.
5. Rubin RH, Tolkoff-Rubin NE. Antimicrobial strategies in the care of organ transplant recipients. Antimicrob Agents Chemother 1993;37:619-24.
6. Limaye AP, Corev L, Koelle DM, Davis CL, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000;356:645-9.
7. Kusne S, Grossi P, Irish W, et al. Cytomegalovirus pp65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1999;68:1125-31.
8. Tong CY, Cuevas L, Williams H, Bakran A. Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients. J Clin Microbiol 1998;36:2681-5. (Erratum in 1999;37:881).
9. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-7.
10. Boeckh M, Boivir G. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 1998;11:533-54.
11. Ljungman P, Plotkin SA. Workshop on CMV disease: Definitions, clinical severity scores, and new syndromes. Scand J Infect Dis 1995;(Suppl 99):87-9.
12. Erice A, Holm MA, Gill PC, et al. Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Mibrobiol 1992;30:2822-5.
13. Storch GA, Buller RS, Bailey TC, et al. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Microbiol 1994;32:997-1003.
14. van den Berg AP, van der Bij W, van Son WJ, et al. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - a report of 130 consecutive patients. Transplantation 1989;48:991-5.
15. Kim CK, Song JH, Kim SM, et al. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation. Transplantation 2003;75:2151-5.
16. Pang XL, Chui L, Fenton J, LeBlanc B, Preiksaitis JK. Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol 2003;41:3167-74.
17. Weinberg A, Hodges TN, Li S, Cai G, Zamora MR. Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J Clin Microbiol 2000;38:768-72.
18. Seehofer D, Meisel H, Rayes N, et al. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation. Am J Transplantation 2004;4:1331-7.
19. Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999;68:1305-11.
20. Degre M, Kristiansen KI, Rollag H, Holter E, Nordal KP. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients. Clin Microbiol Infect 2001;7:254-60.
21. Tanabe K, Tokumoto T, Ishikawa N, et al. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997;64:1721-5.
22. Vivarelli M, De Ruvo N, Lazzarotto T, et al. Abstension from treatment of low-level pp65 cytomegalovirus antigenemia after liver transplantation: A prospective study. Transplantation 2000;70:1183-7.
23. Meyer-Koenig U, Weidmann M, Kirste G, Hufert FT. Cytomegalovirus infection in organ-transplant recipients: Diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and quantitative Taqman PCR. Transplantation 2004;77:1692-8.
24. Senechal M, Dorent R, du Montcel ST, et al. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia. Clin Transplant 2003;17:423-7.